These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2750714)

  • 1. Monocyte monolayer assay: an efficient noninvasive technique for predicting the severity of hemolytic disease of the newborn.
    Nance SJ; Nelson JM; Horenstein J; Arndt PA; Platt LD; Garratty G
    Am J Clin Pathol; 1989 Jul; 92(1):89-92. PubMed ID: 2750714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte monolayer assay as a predictor of severity of hemolytic disease of the fetus and newborn.
    Sacks DA; Nance SJ; Garratty G; Petrucha RA; Horenstein J; Fotheringham N
    Am J Perinatol; 1993 Nov; 10(6):428-31. PubMed ID: 8267805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Spectrophotometric characteristics of the amniotic fluid in Rh isoimmunization following intrauterine fetal blood transfusions].
    Matrova TS; Vasileva Iu
    Akush Ginekol (Sofiia); 1989; 28(1):30-2. PubMed ID: 2500862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting hemolytic disease of the newborn: a comparison of the monocyte monolayer assay and the chemiluminescence test.
    Lucas GF; Hadley AG; Nance SJ; Garratty G
    Transfusion; 1993 Jun; 33(6):484-7. PubMed ID: 8516790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of the hemolytic disease of the newborn depending on the prenatal amniotic fluid findings].
    Mast H; Schellong G
    Dtsch Med Wochenschr; 1967 Nov; 92(46):2106-13. PubMed ID: 6073920
    [No Abstract]   [Full Text] [Related]  

  • 6. Significance of mid-zone fluctuations in amniotic fluid spectrophotometric analysis for Rh-isoimmunization.
    Friedman EA; Charles AG; Alpern WM
    Obstet Gynecol; 1970 Mar; 35(3):358-63. PubMed ID: 5416701
    [No Abstract]   [Full Text] [Related]  

  • 7. The monocyte monolayer assay: a noninvasive technique for predicting the severity of in utero hemolysis.
    Larson PJ; Thorp JM; Miller RC; Hoffman M
    Am J Perinatol; 1995 May; 12(3):157-60. PubMed ID: 7612085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The diagnosis and antenatal prevention of hemolytic disease of the newborn in Rh sensitized women].
    Persianinov LS; Sidel'nikova VM
    Akush Ginekol (Mosk); 1971 Aug; 47(8):3-8. PubMed ID: 4342988
    [No Abstract]   [Full Text] [Related]  

  • 9. [Supervision of pregnant women isoimmunized with the rhesus factor. Significance and interpretation of the position of optic indices on the Liley diagram (425 cases)].
    Blanchard A; Merger R
    J Gynecol Obstet Biol Reprod (Paris); 1972 Mar; 1(2):107-31. PubMed ID: 4626034
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of prenatal amniotic fluid diagnosis in suspected hemolytic disease of newborn].
    Stark VK; Schwarzlos G; During R; Plesse R; Hartwig K
    Zentralbl Gynakol; 1988; 110(1):12-7. PubMed ID: 3354273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spectrophotometric study on the amniotic fluid of Rh-sensitized pregnant females].
    Gulyás P; Lampé L
    Z Geburtshilfe Gynakol; 1971 Apr; 174(2):210-9. PubMed ID: 5005235
    [No Abstract]   [Full Text] [Related]  

  • 12. [A simple interpretation of spectrophotometric curves of amniotic fluid in hemolytic disease of the newborn].
    Baumgarten K; Fröhlich H
    Bibl Haematol; 1969; 32():83-7. PubMed ID: 4980807
    [No Abstract]   [Full Text] [Related]  

  • 13. The value of different methods of amniotic fluid analysis in the diagnosis of Rh hemolytic disease (spectrophotometric and chemical determination of bilirubin, bilirubin-protein ratio, anti-Rho(D) titres).
    Dambrosio F; Della Torre L; Meroni P; Clerici-Bagozzi D
    Ann Ostet Ginecol Med Perinat; 1970 Aug-1971 Aug; 92(8):528-31. PubMed ID: 5001775
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison between the method of Liley and of Whitfield in research work on the amniotic fluid in Rh incompatibility.
    Baumgarten K
    Ann Ostet Ginecol Med Perinat; 1970 Aug-1971 Aug; 92(8):498-500. PubMed ID: 5001770
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prenatal diagnostic and therapeutic possibilities in fetal erythroblastosis].
    Schellong G; Mast H
    Monatsschr Kinderheilkd (1902); 1968 Jun; 116(6):216-20. PubMed ID: 4975895
    [No Abstract]   [Full Text] [Related]  

  • 16. Maternal Kell blood group alloimmunization.
    Bowman JM; Pollock JM; Manning FA; Harman CR; Menticoglou S
    Obstet Gynecol; 1992 Feb; 79(2):239-44. PubMed ID: 1731292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spectrophotometric analysis of amniotic fluid prenatal diagnosis of fetal erythroblastosis].
    Radzuweit H; Eckert L; Zachäus V; Weigel W
    Zentralbl Gynakol; 1971 Mar; 93(12):380-7. PubMed ID: 4995302
    [No Abstract]   [Full Text] [Related]  

  • 18. [Functional evaluation of erythrocytic antibodies by photometric detection of erythrophagocytosis in the monocyte monolayer assay].
    Cassens U; Garritsen HS; Sibrowski W; Holzgreve W
    Geburtshilfe Frauenheilkd; 1996 Jun; 56(6):297-300. PubMed ID: 8766487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New possibilities in diagnosing hemolytic disease of newborn infants].
    Fischer K; Poschmann A; Grundmann A; Asmussen S
    Beitr Infusionsther; 1992; 30():431-5. PubMed ID: 1284753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the amniotic fluid in rhesus sensitized pregnancies for the evaluation of severity of fetal hemolytic disease].
    Janev A; Aleksić M; Begić-Janeva A
    Srp Arh Celok Lek; 1986 Mar; 114(3):273-87. PubMed ID: 3147517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.